Newsworthy

Crohn’s Disease Clinical Trial Recruitment

The AFFIRM Study is looking for adults who are 18 years of age or older, with moderate to severe Crohn’s disease (CD). The study is researching a study drug to see if it can safely be given subcutaneously (an injection under the skin) with the goal of inducing “remission” in adults with CD. Remission is the point where CD symptoms start to go away or disappear completely. To see whether you might be eligible, please visit our website www.AFFIRMstudyCD.com, or contact the Cotton O’Neil Digestive Health Clinical Research Center to learn more: (785) 270-4856.

Posted in

In Other News

Stormont Vail Community News 6.03.25

060325a

Stormont Vail Health Leads the Way with Robotic-Assisted Bronchoscopy in Topeka

ION Robotic Bronchoscopy_Pulm. Care-Web page

Stormont Vail Community News 5.27.25

052725a

Stormont Vail Community News 5.20.25

svh_generic_tb_2025

We Celebrate Candace Huber: April 2025 Person of the Moment

2025_April_POM Candace Huber-StormConn